定量系统药理学用于罕见疾病 药物开发 药物开发
Jane Pf Bai1, Jie Wang1, Yifei Zhang1
1Office of Clinical Pharmacology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, USA.
Journal of pharmaceutical sciences
|July 8, 2023
概括
定量系统药理学 (QSP) 通过解决有效性和安全性挑战,帮助开发罕见病药物. QSP模型可以模拟疾病的进展,并使体试验成为可能,加速治疗创新以满足未满足的医疗需求.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
- 药物开发 药物开发
背景情况:
- 大多数罕见疾病缺乏FDA批准的治疗方法,尽管有大量的药物批准.
- 在罕见疾病中证明药物的有效性和安全性存在重大挑战.
研究的目的:
- 探索开发罕见疾病治疗方法的机会.
- 突出量化系统药理学 (QSP) 在克服罕见疾病药物开发障碍方面的作用.
主要方法:
- 对量化系统药理学 (QSP) 提交给FDA的分析 (2022年为121件).
- 对已发表的QSP模型进行检查,检查代谢的先天性错误,血液学疾病和恶性瘤.
- 探索QSP在模拟罕见疾病自然史和进行in-silico试验方面的潜力.
主要成果:
- QSP越来越多地被用来为不同阶段和治疗领域的罕见病药物开发提供信息.
- QSP模型可以整合遗传异质性和疾病模拟的临床表现.
- 技术的进步使QSP有可能进行in-silico试验.
结论:
- 定量系统药理学 (QSP) 在促进罕见疾病安全有效药物的开发方面显示出显著的前景.
- QSP可以帮助克服罕见病药物开发中的关键挑战,解决未满足的医疗需求.
- 预计QSP的应用将不断增长,在未来治疗罕见疾病的创新中发挥关键作用.
相关概念视频
Pharmacokinetic Models: Overview
809
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
809
Analysis of Population Pharmacokinetic Data
300
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
300
Pharmacokinetic Models: Comparison and Selection Criterion
109
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
109
Structure-Activity Relationships and Drug Design
789
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
789
Quantitative Aspects of Drug-Receptor Interaction
1.0K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.0K
Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K


